something's up, page-10

The volume today is probably a combination of things.

* Buying the pharmaceutical plant in Canada on the cheap, worth(25mill canadian) only owe 3+millC on it...not due till 2013

*FDA lastest announcement.

*Sales in Aus predicted to be around 600k per month by Sept/Oct

*Successful independent trials for Aids/TB/influenza

*Expected sale of office in Sydney $2mill+

*Government grants in advance process of $3.5mill+

Looks good for a 1c company

Cheers :-)